ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q2 2022$495,000
-89.7%
15,945
-80.3%
0.00%
-92.3%
Q4 2018$4,807,000
+33.3%
81,093
+48.0%
0.01%
+62.5%
Q3 2018$3,607,000
+162.7%
54,800
+101.5%
0.01%
+166.7%
Q2 2018$1,373,000
-54.0%
27,192
-52.1%
0.00%
-57.1%
Q1 2018$2,988,000
-64.6%
56,761
-80.4%
0.01%
-77.4%
Q1 2017$8,429,000290,2660.03%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Zebra Capital Management LLC 25,250$784,0002.30%
Global Alpha Capital Management Ltd. 418,030$12,976,0001.40%
AIMZ Investment Advisors, LLC 70,588$2,191,0001.05%
PALISADE CAPITAL MANAGEMENT, LP 566,080$17,571,0000.48%
RICE HALL JAMES & ASSOCIATES, LLC 261,533$8,118,0000.39%
EARNEST PARTNERS LLC 1,844,621$57,257,0000.38%
SummerHaven Investment Management, LLC 14,476$449,0000.30%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,085,874$33,706,0000.26%
Ridgewood Investments LLC 10,004$311,0000.24%
DUALITY ADVISERS, LP 65,650$2,038,0000.20%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders